SWOG clinical trial number
SWOG-9333

A Randomized Controlled Trial of Mitoxantrone and Etoposide versus Daunomycin and Cytosine Arabinoside as Induction Therapy in Patients Over Age 55 With Previously Untreated Acute Myeloid Leukemia, Phase III

84% Accrual
Accrual
84%
Closed
Phase
84% Accrual
Accrual
84%
Published
Abbreviated Title
Mito/VP-16 vs DNR/Ara-C for Elderly AML
Activated
01/15/1995
Closed
12/01/1998
Participants

Research committees

Leukemia

Treatment

Cytosine Arabinoside Daunomycin GM-CSF Mitoxantrone VP-16